Ibalizumab
22 March 2023. Related: ARVs, Entry inhibitors, monoclonal antibody (mAb)
Ibalizumab is a 200 mg concentrate that is then made up as an infusion.
22 March 2023. Related: ARVs, Entry inhibitors, monoclonal antibody (mAb)
Ibalizumab is a 200 mg concentrate that is then made up as an infusion.